These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7652635)

  • 1. Ketanserin and hydralazine in hypertension in pregnancy--a randomised double-blind trial.
    Rossouw HJ; Howarth G; Odendaal HJ
    S Afr Med J; 1995 Jun; 85(6):525-8. PubMed ID: 7652635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should continuous hydralazine infusions be utilized in severe pregnancy-induced hypertension?
    Kirshon B; Wasserstrum N; Cotton DB
    Am J Perinatol; 1991 May; 8(3):206-8. PubMed ID: 2029282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe hypertension in pregnancy: hydralazine or labetalol. A randomized clinical trial.
    Vigil-De Gracia P; Lasso M; Ruiz E; Vega-Malek JC; de Mena FT; López JC;
    Eur J Obstet Gynecol Reprod Biol; 2006; 128(1-2):157-62. PubMed ID: 16621226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative trial of labetalol and hydralazine in the acute management of severe hypertension complicating pregnancy.
    Mabie WC; Gonzalez AR; Sibai BM; Amon E
    Obstet Gynecol; 1987 Sep; 70(3 Pt 1):328-33. PubMed ID: 3306494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The optimal dosage of ketanserin for patients with severe hypertension in pregnancy.
    van Schie DL; de Jeu RM; Steyn DW; Odendaal HJ; van Geijn HP
    Eur J Obstet Gynecol Reprod Biol; 2002 May; 102(2):161-6. PubMed ID: 11950484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Oral ketanserin in the treatment of pre-eclampsia].
    Hulme VA; Odendaal HJ
    S Afr Med J; 1988 Jul; 74(2):61-2. PubMed ID: 3399973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ketanserin versus dihydralazine for the treatment of severe hypertension in early-onset preeclampsia: a double blind randomized controlled trial.
    Bijvank SW; Visser W; Duvekot JJ; Steegers EA; Edens MA; Roofthooft DW; Vulto AG; Hanff LM
    Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():106-11. PubMed ID: 25892082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic effects of intravenous hydralazine in pregnant women with severe hypertension.
    Kuzniar J; Skret A; Piela A; Szmigiel Z; Zaczek T
    Obstet Gynecol; 1985 Oct; 66(4):453-8. PubMed ID: 4047535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood pressure patterns in pregnant patients on oral ketanserin.
    Steyn DW; Odendaal HJ
    Cardiovasc J S Afr; 2001; 12(2):82-7. PubMed ID: 11447496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomised comparison of hydralazine and mini-bolus diazoxide for hypertensive emergencies in pregnancy: the PIVOT trial.
    Hennessy A; Thornton CE; Makris A; Ogle RF; Henderson-Smart DJ; Gillin AG; Child A
    Aust N Z J Obstet Gynaecol; 2007 Aug; 47(4):279-85. PubMed ID: 17627681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of hydralazine on placental and renal circulation in pre-eclampsia.
    Gudmundsson S; Gennser G; Marsal K
    Acta Obstet Gynecol Scand; 1995 Jul; 74(6):415-8. PubMed ID: 7604682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of severe hypertension in the postpartum period with intravenous hydralazine or labetalol: a randomized clinical trial.
    Vigil-De Gracia P; Ruiz E; López JC; de Jaramillo IA; Vega-Maleck JC; Pinzón J
    Hypertens Pregnancy; 2007; 26(2):163-71. PubMed ID: 17469006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risks of parenteral antihypertensive therapy for the treatment of severe maternal hypertension are low.
    Sharma KJ; Rodriguez M; Kilpatrick SJ; Greene N; Aghajanian P
    Hypertens Pregnancy; 2016; 35(1):123-8. PubMed ID: 26910380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of maternal ketanserin use on the circulation of the neonate: a prospective, observational study.
    Schaafstra L; van Roon EN; Morssink LP; de Vries NK
    Eur J Obstet Gynecol Reprod Biol; 2012 May; 162(1):11-5. PubMed ID: 22349270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nifedipine or hydralazine as a first-line agent to control hypertension in severe preeclampsia.
    Aali BS; Nejad SS
    Acta Obstet Gynecol Scand; 2002 Jan; 81(1):25-30. PubMed ID: 11942883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insufficient efficacy of intravenous ketanserin in severe early-onset pre-eclampsia.
    Hanff LM; Visser W; Roofthooft DW; Vermes A; Hop WC; Steegers EA; Vulto AG
    Eur J Obstet Gynecol Reprod Biol; 2006; 128(1-2):199-203. PubMed ID: 16386829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of nifedipine on fetal umbilical artery Doppler waveforms in pregnancies complicated by hypertension.
    Puzey MS; Ackovic KL; Lindow SW; Gonin R
    S Afr Med J; 1991 Feb; 79(4):192-4. PubMed ID: 1996435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Propranolol-hydralazine combination in essential hypertension.
    Stevens JD; Binstok G; Mullane JF; Woods JW; Pittman AW; del Greco F; Huang C; Morledge JH
    Clin Ther; 1983; 5(5):525-39. PubMed ID: 6352036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dihydralazine or ketanserin for severe hypertension in pregnancy? Preliminary results.
    Steyn DW; Odendaal HJ
    Eur J Obstet Gynecol Reprod Biol; 1997 Dec; 75(2):155-9. PubMed ID: 9447368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ketanserin, hypertension, and chronic alcoholism: double-blind study in forty patients.
    de Lorenzo A; Ceccanti M; Assogna G; Romeo M; Cavaleri G; Attilia ML
    Int J Clin Pharmacol Res; 1988; 8(5):321-5. PubMed ID: 3068159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.